SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-013788
Filing Date
2022-05-27
Accepted
2022-05-27 16:01:38
Documents
15
Period of Report
2022-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cenb20220526_8k.htm   iXBRL 8-K 33959
2 EXHIBIT 10.1 ex_381001.htm EX-10.1 67898
3 EXHIBIT 10.2 ex_381002.htm EX-10.2 86880
  Complete submission text file 0001437749-22-013788.txt   355362

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA noticker-20220524.xsd EX-101.SCH 3634
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20220524_def.xml EX-101.DEF 10819
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20220524_lab.xml EX-101.LAB 14417
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20220524_pre.xml EX-101.PRE 10865
9 EXTRACTED XBRL INSTANCE DOCUMENT cenb20220526_8k_htm.xml XML 2380
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55557 | Film No.: 22977199
SIC: 2834 Pharmaceutical Preparations